We are live on ! Find out more
CODX icon

Co-Diagnostics
CODX

25 hedge funds and large institutions have $1.85M invested in Co-Diagnostics in 2026 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

26,639% more capital inflows, than outflows

Capital inflows: $1.69M | Capital outflows: $6.31K

550% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 2

100% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 2

79% more funds holding

Funds holding: 14 → 25 (+11)

8.53% more ownership

Funds ownership: 0% → 8.53% (+8.5%)

Holders
25
Holders Change
+11
Holders Change %
+78.57%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
4
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Armistice Capital
Armistice Capital
New York
+$726K
2
Jane Street
Jane Street
New York
+$275K
3
Vanguard Capital Management
Vanguard Capital Management
Pennsylvania
+$179K
4
Millennium Management
Millennium Management
New York
+$98.4K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$96.1K

Top Sellers

Rank Fund Capital Flow
1
Private Advisory Group
Private Advisory Group
Washington
-$6.15K
2
JP Morgan Chase
JP Morgan Chase
New York
-$145
3
Danske Bank
Danske Bank
Denmark
-$13
4
Citigroup
Citigroup
New York
-$2

CODX Hedge Fund Activity: Q2 2026 in Review

25 of the 8,371 institutional investors tracked by Wall St. Rank reported a position in Co-Diagnostics (CODX) for Q2 2026, worth a combined $1.85M — up 1,919% from $91.5K a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new CODX positions and 2 closed out — a net gain of 11 holders — while 4 added to existing stakes and 2 trimmed.

The largest buyer was Armistice Capital, opening a new position worth an estimated $726K. The largest seller was Private Advisory Group, cutting an estimated $6.15K.

  • 25 institutional investors held Co-Diagnostics (CODX) as of Q2 2026, up from 14 in Q1 2026.
  • Funds reported $1.85M of Co-Diagnostics stock for Q2 2026, up 1,919% quarter-over-quarter.
  • 13 funds opened new Co-Diagnostics positions in Q2 2026 and 2 closed out, a net change of +11 holders.
  • The largest Co-Diagnostics buyer in Q2 2026 was Armistice Capital, an estimated $726K added.
  • The largest Co-Diagnostics seller in Q2 2026 was Private Advisory Group, an estimated $6.15K sold.

Based on aggregated 13F filings for Q2 2026.